Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 2
2017 4
2018 6
2019 5
2020 10
2021 9
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

35 results
Results by year
Filters applied: . Clear all
Page 1
Sintilimab plus IBI305 for hepatocellular carcinoma.
Bomze D, Meirson T, Azoulay D. Bomze D, et al. Among authors: meirson t. Lancet Oncol. 2021 Sep;22(9):e386. doi: 10.1016/S1470-2045(21)00388-0. Lancet Oncol. 2021. PMID: 34478670 No abstract available.
A critique of the fragility index.
Bomze D, Meirson T. Bomze D, et al. Among authors: meirson t. Lancet Oncol. 2019 Oct;20(10):e551. doi: 10.1016/S1470-2045(19)30582-0. Epub 2019 Sep 30. Lancet Oncol. 2019. PMID: 31578993 No abstract available.
Atezolizumab and Bevacizumab in Hepatocellular Carcinoma.
Bomze D, Meirson T, Azoulay D. Bomze D, et al. Among authors: meirson t. N Engl J Med. 2020 Aug 13;383(7):693-694. doi: 10.1056/NEJMc2021840. N Engl J Med. 2020. PMID: 32786198 No abstract available.
Invasion and metastasis: the elusive hallmark of cancer.
Meirson T, Gil-Henn H, Samson AO. Meirson T, et al. Oncogene. 2020 Feb;39(9):2024-2026. doi: 10.1038/s41388-019-1110-1. Epub 2019 Nov 19. Oncogene. 2020. PMID: 31745295 No abstract available.
35 results